NCT06201351View on ClinicalTrials.gov

Study of Adaptive Radiotherapy for High-grade Glioma Based on Interfraction MRI

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

September 30, 2026

Conditions
High-grade Glioma
Interventions
DEVICE

adaptive radiotherapy

MRI was performed and adaptive radiotherapy was administered at farction10 and fraction 20 during radiotherapy.

Trial Locations (1)

610041

West China Hospital, Chengdu

All Listed Sponsors
lead

West China Hospital

OTHER

NCT06201351 - Study of Adaptive Radiotherapy for High-grade Glioma Based on Interfraction MRI | Biotech Hunter | Biotech Hunter